Glucotrack (GCTK) Cash & Equivalents Growth (1y) (2011 - 2025)
Glucotrack (GCTK) Cash & Equivalents Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -19.91% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -3.67% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -3.76% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 21.48% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -14.50% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -18.09% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 19.45% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 27.52% |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - | -88.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.44% |
| Mar 31, 2025 | 507.88% |
| Dec 31, 2024 | 25.04% |
| Sep 30, 2024 | -94.98% |
| Jun 30, 2024 | -98.19% |
| Mar 31, 2024 | 49.25% |
| Dec 31, 2023 | 94.29% |
| Sep 30, 2023 | 112.53% |
| Jun 30, 2023 | 127.66% |
| Mar 31, 2023 | -79.06% |
| Dec 31, 2022 | -61.86% |
| Sep 30, 2022 | -53.70% |
| Jun 30, 2022 | -51.17% |
| Mar 31, 2022 | -46.11% |
| Dec 31, 2021 | -38.29% |
| Sep 30, 2021 | -34.62% |
| Jun 30, 2021 | -31.45% |
| Mar 31, 2021 | -28.46% |
| Dec 31, 2020 | 2,244.39% |
| Sep 30, 2020 | 775.96% |